iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMAI Capital Management
Latest Disclosed Ownership81,832 shares
Latest Disclosed Value $ 13,817,305
MAI Capital Management ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - MAI Capital Management filed a 13F-HR form disclosing ownership of 81,832 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $13,817,305 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 80,461 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 1.70% during the quarter. The current value of the position is $10,724,084 USD.

MAI Capital Management has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 81,832 1,371 1.70 13,817 1.75 0.0780
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 80,461 4,080 5.34 13,579 23.14 0.0781
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 76,381 6,035 8.58 11,027 23.91 0.0687
2025-08-12 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 70,346 -27,812 -28.33 8,899 -29.11 0.0615
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 98,158 3,923 4.16 12,554 0.77 0.0946
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 94,235 4,833 5.41 12,459 -4.29 0.0923
2024-11-07 2024-09-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 89,402 -1,081 -1.19 13,017 4.81 0.1239
2024-08-12 2024-06-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 90,483 33,844 59.75 12,420 59.81 0.1217
2024-05-08 2024-03-31 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 56,639 -924 -1.61 7,772 -0.61 0.0805
2024-02-09 2023-12-31 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 57,563 -6,679 -10.40 7,820 -0.47 0.1028
2023-11-14 2023-09-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 64,242 -1,471 -2.24 7,856 -5.83 0.1168
2023-08-02 2023-06-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 65,713 -2,171 -3.20 8,343 -4.85 0.1228
2023-05-10 2023-03-31 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 67,884 1,054 1.58 8,768 -0.08 0.1381
2023-02-09 2022-12-31 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 66,830 2,776 4.33 8,774 17.11 0.1474
2022-11-15 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 64,054 6,535 11.36 7,492 10.73 0.1407
2022-07-19 2022-06-30 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 57,519 17,160 42.52 6,766 28.66 0.1292
2022-05-10 2022-03-31 13F ISHARES BIOTECHNOLOGY ETF EE 464287556 40,359 -5,503 -12.00 5,259 -24.86 0.0884
2022-02-11 2021-12-31 13F iShares NASDAQ Biotech Index EE 464287556 45,862 32,221 236.21 6,999 217.27 0.1128
2021-11-12 2021-09-30 13F iShares NASDAQ Biotech Index EE 464287556 13,641 10,511 335.81 2,206 330.86 0.0425
2021-07-19 2021-06-30 13F iShares NASDAQ Biotech Index EE 464287556 3,130 246 8.53 512 17.97 0.0102
2021-05-10 2021-03-31 13F iShares NASDAQ Biotech Index EE 464287556 2,884 765 36.10 434 35.20 0.0097
2021-02-16 2020-12-31 13F iShares NASDAQ Biotech Index EE 464287556 2,119 -20 -0.94 321 10.69 0.0080
2020-10-26 2020-09-30 13F iShares NASDAQ Biotech Index EE 464287556 2,139 22 1.04 290 0.35 0.0084
2020-07-27 2020-06-30 13F iShares NASDAQ Biotech Index EE 464287556 2,117 2,117 289 0.0091
2018-04-17 2018-03-31 13F iShares NASDAQ Biotech Index EE 464287556 0 -3,186 -100.00 0 -100.00
2018-01-30 2017-12-31 13F iShares NASDAQ Biotech Index EE 464287556 3,186 2,150 207.53 340 -1.73 0.0193
2017-10-12 2017-09-30 13F iShares NASDAQ Biotech Index EE 464287556 1,036 30 2.98 346 10.90 0.0210
2017-08-07 2017-06-30 13F iShares NASDAQ Biotech Index EE 464287556 1,006 0 0.00 312 5.76 0.0201
2017-05-11 2017-03-31 13F iShares NASDAQ Biotech Index EE 464287556 1,006 -3,384 -77.08 295 -74.68 0.0198
2017-01-31 2016-12-31 13F iShares NASDAQ Biotech Index EE 464287556 4,390 1,114 34.00 1,165 22.89 0.0847
2016-10-18 2016-09-30 13F iShares NASDAQ Biotech Index EE 464287556 3,276 94 2.95 948 15.75 0.0715
2016-07-14 2016-06-30 13F iShares NASDAQ Biotech Index EE 464287556 3,182 40 1.27 819 0.00 0.0631
2016-04-08 2016-03-31 13F iShares NASDAQ Biotech Index EE 464287556 3,142 310 10.95 819 -14.51 0.0626
2016-01-27 2015-12-31 13F iShares NASDAQ Biotech Index EE 464287556 2,832 145 5.40 958 17.55 0.0730
2015-10-28 2015-09-30 13F iShares NASDAQ Biotech Index EE 464287556 2,687 969 56.40 815 28.55 0.0616
2015-07-09 2015-06-30 13F iShares NASDAQ Biotech Index EE 464287556 1,718 1,718 634 0.0418
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-07-19 2021-06-30 13F iShares NASDAQ Biotech Index EE Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-10 2021-03-31 13F iShares NASDAQ Biotech Index EE Put 400 60 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.